Antibodies to non-bilayer phospholipid arrangements induce a murine autoimmune disease resembling human lupus

European Journal of Immunology

Volumn 34, Issue 2, 2004, Pages 576-586

  Baeza, Isabel ^a   Leyva, Emma ^a   Campos, Begoña ^b   Lara, Mónica ^a   Ibáñez, Miguel ^a   Farfán, Norberto ^c   Orozco, Héctor ^d   Flores Romo, Leopoldo ^c   Hernández Pando, Rogelio ^d   Wong, Carlos ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSITY OF CINCINNATI   (United States)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d National Institute of Medicine Sciences and Nutrition Salvador Subirán   (Mexico)

Author keywords

Autoantibodies; Autoimmune diseases; Lupus like; Murine lupus; Non bilayer phospholipids

Indexed keywords

ALBUMIN; CHLORPROMAZINE; CREATININE; LIPOSOME; MONOCLONAL ANTIBODY; PHOSPHOLIPID; PROCAINAMIDE; ANTIARRHYTHMIC AGENT; AUTOANTIBODY; NEUROLEPTIC AGENT;

ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CELL MEMBRANE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; IMMUNOLOGY; IN VIVO STUDY; LUPUS ERYTHEMATOSUS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; GERMFREE ANIMAL; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTIPSYCHOTIC AGENTS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHLORPROMAZINE; DISEASE MODELS, ANIMAL; FEMALE; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED BALB C; PHOSPHOLIPIDS; PROCAINAMIDE; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 1642373184     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324177     Document Type: Article

References (32)

1. Cullis, P. R., Tilcock, C. P. and Hope, M. J., Lipid polymorphism. In Wilschut, J. and Hoekstra, D. (Eds.) Membrane fusion. Marcel Dekker, New York 1991, pp 35-64.
2. Baeza, I., Wong, C., Mondragón, R., González, S., Ibáñez, M., Farfán, N. and Argüello, C., Transbilayer diffusion of divalent cations mediated by phosphatidate particles. J. Mol. Evol. 1994. 39: 560-568.
3. Baeza, I., Aguilar, L., Escobar, A., Mondragón, R., González, S., Ibáñez, M. and Wong, C., Identification of phosphatidate nonlamellar phases on liposomes by flow cytometry. Biochem. Cell Biol. 1995. 73: 289-297.
4. Aguilar, L., Ortega, G., Campos, B., Ibáñez, M., Wong, C., Farfán, N., Naciff, J., Kaetzel, M., Dedman, J. and Baeza, I., Phospholipid membranes form specific nonbilayer molecular arrangements that are antigenic. J. Biol. Chem. 1999. 274: 25193-25196.
5. Ibáñez, M., Gariglio, P., Chávez, P., Santiago, R., Wong, C. and Baeza, I., Spermidine-condensed DNA and cone-shaped lipids improve delivery and expression of exogenous DNA transfer by liposomes. Biochem. Cell Biol. 1996. 74: 633-643.
6. Hafez, M. and Cullis, P. R., Roles of lipid polymorphism in intracellular delivery. Adv. Drug Deliv. Rev. 2001. 47: 139-148.
7. Wegener, J. and Galla, H.-J., Role of non-lamellar lipid structures in formation of tight junctions. Chem. Phys. Lipids 1996. 81: 229-255.
8. van den Brink-van der Laan, E., Dalbey, R., Demel, A., Killian, J. A. and de Kruijff, B., Effect of nonbilayer lipids on membrane binding and insertion of catalytic domain of leader peptidase. Biochemistry 2001. 40: 9677-9684.
9. Morein, S., Anderson, A.-S., Rilfors, L. and Lindblom, G., Wild type Escherichia coli regulate membrane lipid composition in a "window" between gel and non-lamellar structures. J. Biol. Chem. 1996. 271: 6801-6809.
10. 2-glycoprotein I (apolipoprotein H). Proc. Nat. Acad. Sci. USA 1990. 87: 4120-4124.
11. Sugi, T. and McIntyre, A., Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995. 86: 3083-3089.
12. Arnout, J., Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants. Thromb. Haemost. 2001. 86: 83-91.
13. Rauch, J., Tannenbaum, M., Neville, C. and Fortin, R., Inhibition of lupus anticoagulant activity by hexagonal-phase PE in presence of prothrombin. Thromb. Haemost. 1998. 80: 936-941.
14. 31P-NMR and DSC characterization of a novel lipid organization in calcium-dioleoylphosphatidate membranes. Implications for the mechanism of phosphatidate-calcium transmembrane-shuttle. Biochim. Biophys. Acta 1987. 897: 453-466.
15. Zazueta, C., Ramírez, J., García, N. and Baeza, I., Cardiolipin regulates activity of reconstituted mitochondrial calcium uniporter by modifying the structure of liposome bilayer. J. Membrane Biol. 2003. 191: 113-122.
16. Sammaritano, L. R., Drug-induced antiphospholipid antibodies. In Khamashta M. A. (Ed.) Hughes syndrome, Antiphospholipid syndrome. Springer, London 2000, pp 144-154.
17. Verkleij, A. J., de Maagd, R., Levnissen-Bijvelt, J. and de Kruijff, B., Divalent cations and chlorpromazine can induce non-bilayer structures in phosphatidic acid-containing model membranes. Biochim. Biophys. Acta 1982. 684: 255-262.
18. Jerdan, M. S., Hood, F., Moore, W. and Callen, P., Histopathologic comparison of subsets of lupus erythematosus. Arch. Dermathol. 1990. 126: 52-60.
19. Farrugia, E., Torres, V., Gastineau, D., Michet, C. and Holley, E., Lupus anticoagulant in systemic lupus erythematosus: clinical and renal pathological study. Am. J. Kidney Dis. 1992. 20: 463-471.
20. Lillicrap, M., Wright, G. and Jones, C., Symptomatic antiphospholipid syndrome induced by chlorpromazine. Br. J. Rheumatol. 1998. 37: 346-347.
21. Subang, R., Levine, S., Janoff, S., Davidson, M., Taraschi, F., Koike, T., Minchey, S., Whiteside, M., Tannenbaum, M. and Rauch, J., Phospholipid-bound β2-glycoprotein I induces production of anti-phospholipid antibodies. J. Autoimmun. 2000. 15: 21-31.
22. Levine, J. S., Koh, S., Subang, R. and Rauch, J., Apoptotic cells as immunogen and antigen in antiphospholipid syndrome. Exp. Mol. Pathol. 1999. 66: 82-98.
23. Wakeland, E., Liu, K., Graham, R. and Behrens, W., Delineating genetic basis of systemic lupus erythematosus. Immunity 2001. 15: 397-408.
24. Hieronymus, T., Grötsch, P., Blank, N., Grünke, M., Capraru, D., Geiler, T., Winkler, S., Kalden, J. and Lorenz, H., Chlorpromazine induces apoptosis in activated human lymphoblasts. Arthritis Rheum. 2000. 43: 1994-2004
25. Mevorach, D., Zhou, J., Song, X. and Elkon, K., Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. 1998. 18: 387-392.
26. Loizou, S., McCrea, D., Rudge, A. C., Reynolds, R., Boyle, C. and Harris, E. N., Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantitation of results. Clin. Exp. Immunol. 1985. 62: 738-745.
27. van den Besselaar, A., Meeuwisse-Braun, J., Jansen-Gruter, R. and Bertina, R. M., Monitoring heparin therapy by activated partial thromboplastin time. Effect of pre-analytical conditions. Thromb. Haemost. 1987. 57: 226-231.
28. Molden, P., Nakamura, R. M. and Tan, E. M., Standardization of immunofluorescence test for autoantibody to nuclear antigens (ANA): Use of reference-sera of defined antibody specificity. J. Clin. Pathol. 1984. 82: 57-62.
29. Costa, O. and Monier, J., Antihistone antibodies detected by Micro-ELISA and immunoblotting in mice with lupus-like syndrome (MRL/l, MRL/n, PN, and NZB strains). Clin. Immunol. Immunopathol. 1986. 40: 276-282.
30. Jay, W., Nonprotein nitrogen. In Bishop, L., Duben-Engelkirk, L. and Fody, P. (Eds.) Clinical chemistry. Principles, procedures, correlations. Lippincott, Williams and Wilkins, Philadelphia 2000, pp 260-274.
31. Lindsey, J., Amino acids and proteins. In Bishop, L., Duben-Engelkirk, L. and Fody, P. (Eds.) Clinical chemistry. Principles, procedures, correlations. Lippincott, Williams and Wilkins, Philadelphia 2000, pp 151-184.
32. Everett, R. M. and Harrison, S. Jr., Clinical biochemistry. In Foster, H. L., Small, J. and Fox, J. G. (Eds.) The mouse in biomedical research. Academic Press, New York 1983, pp 313-326.